ID   MOLM-13
AC   CVCL_2119
SY   MOLM13; Molm13; Molm 13
DR   BTO; BTO_0004175
DR   CLO; CLO_0009848
DR   EFO; EFO_0022694
DR   AddexBio; C0003003/60
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 403
DR   BioSample; SAMN03473102
DR   BioSample; SAMN10988379
DR   cancercelllines; CVCL_2119
DR   Cell_Model_Passport; SIDM00437
DR   ChEMBL-Cells; CHEMBL3706573
DR   ChEMBL-Targets; CHEMBL3706572
DR   Cosmic; 787417
DR   Cosmic; 947367
DR   Cosmic; 975274
DR   Cosmic; 996319
DR   Cosmic; 998754
DR   Cosmic; 999722
DR   Cosmic; 999772
DR   Cosmic; 1012095
DR   Cosmic; 1037671
DR   Cosmic; 1078734
DR   Cosmic; 1150897
DR   Cosmic; 1152711
DR   Cosmic; 1187863
DR   Cosmic; 1197930
DR   Cosmic; 1278778
DR   Cosmic; 1281332
DR   Cosmic; 1308222
DR   Cosmic; 1465952
DR   Cosmic; 1696139
DR   Cosmic; 1741687
DR   Cosmic; 2089664
DR   Cosmic; 2131546
DR   Cosmic; 2306220
DR   Cosmic; 2750864
DR   Cosmic; 2842299
DR   Cosmic-CLP; 1330947
DR   DepMap; ACH-000362
DR   DSMZ; ACC-554
DR   DSMZCellDive; ACC-554
DR   EDITGENE; EDC00312
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1330947
DR   GEO; GSM482509
DR   GEO; GSM887329
DR   GEO; GSM888405
DR   GEO; GSM1374688
DR   GEO; GSM1374689
DR   GEO; GSM1446738
DR   GEO; GSM1670124
DR   GEO; GSM2124117
DR   GEO; GSM2716691
DR   GEO; GSM2716692
DR   GEO; GSM2716748
DR   GEO; GSM2716749
DR   GEO; GSM2716750
DR   GEO; GSM2716751
DR   IARC_TP53; 30123
DR   JCRB; JCRB1810
DR   LiGeA; CCLE_282
DR   LINCS_LDP; LCL-1061
DR   PharmacoDB; MOLM13_950_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2119
DR   PubChem_Cell_line; CVCL_2119
DR   Wikidata; Q54906320
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9305600;
RX   PubMed=10233379;
RX   PubMed=10637496;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=12529668;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=15381384;
RX   PubMed=16408098;
RX   PubMed=22354205;
RX   PubMed=22460905;
RX   PubMed=23955599;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=27750403;
RX   PubMed=28052028;
RX   PubMed=28109323;
RX   PubMed=28196595;
RX   PubMed=29491412;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=33669837;
RX   PubMed=35839778;
RX   PubMed=36982453;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/leukemia-xenograft-model/molm13-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 3-4 days (PubMed=9305600); 24 hours (PubMed=25984343); 41.1 hours (PubMed=28052028); ~50 hours (DSMZ=ACC-554).
CC   HLA typing: A*26:01:01,31:01:02; B*44:03:01,51:01:01; C*14:02:01,14:03 (DSMZCellDive=ACC-554).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=9305600; PubMed=14671638; PubMed=15381384).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Unexplicit; Internal tandem duplication (FLT3-ITD); ClinVar=VCV000016270; Zygosity=Heterozygous (PubMed=10233379; PubMed=12529668; PubMed=27750403; DepMap; ACH-000362).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.24%; East Asian, North=76.64%; East Asian, South=22.12%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): AddexBio=C0003003/60; COG; Cosmic-CLP=1330947; DSMZ=ACC-554; JCRB=JCRB1810; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10 (AddexBio=C0003003/60)
ST   CSF1PO: 10,12 (COG; Cosmic-CLP=1330947; DSMZ=ACC-554; JCRB=JCRB1810; PubMed=25877200)
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D18S51: 13,15
ST   D19S433: 12,14
ST   D21S11: 30,31
ST   D2S1338: 23,25
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 18,19
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7916 ! MOLM-14
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 25-06-26; Version: 48
CH   CVCL_F5QZ ! EDITGENE MOLM-13-Cas9
CH   CVCL_F6CH ! EDITGENE MOLM-13-CopGFP
CH   CVCL_F5V0 ! EDITGENE MOLM-13-FLUC
CH   CVCL_F1S3 ! HyCyte MOLM-13 KO-hADGRE2
CH   CVCL_F1S4 ! HyCyte MOLM-13 KO-hPTEN
CH   CVCL_D779 ! MOLM-13-RES
CH   CVCL_C0WJ ! MOLM-13/AZA
CH   CVCL_C0WK ! MOLM-13/DAC
CH   CVCL_WI20 ! MOLM/AZA-1
CH   CVCL_WI21 ! MOLM/DEC-5
CH   CVCL_RS50 ! MOLM13rARA-C2mug/ML
//
RX   PubMed=14504097; DOI=10.1182/blood-2003-02-0418;
RA   Taketani, Takeshi
RA   Taki, Tomohiko
RA   Sugita, Kanji
RA   Furuichi, Yoshiyuki
RA   Ishii, Eiichi
RA   Hanada, Ryoji
RA   Tsuchida, Masahiro
RA   Sugita, Kenichi
RA   Ida, Kohmei
RA   Hayashi, Yasuhide
RT   "FLT3 mutations in the activation loop of tyrosine kinase domain are
RT   frequently found in infant ALL with MLL rearrangements and pediatric
RT   ALL with hyperdiploidy.";
RL   Blood 103:1085-1088(2004).
//
RX   PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775;
RA   Goncalves, Emanuel
RA   Poulos, Rebecca C.
RA   Cai, Zhao-Xiang
RA   Barthorpe, Syd
RA   Manda, Srikanth S.
RA   Lucas, Natasha
RA   Beck, Alexandra
RA   Bucio-Noble, Daniel
RA   Dausmann, Michael
RA   Hall, Caitlin
RA   Hecker, Michael
RA   Koh, Jennifer
RA   Lightfoot, Howard
RA   Mahboob, Sadia
RA   Mali, Iman
RA   Morris, James
RA   Richardson, Laura
RA   Seneviratne, Akila J.
RA   Shepherd, Rebecca
RA   Sykes, Erin
RA   Thomas, Frances
RA   Valentini, Sara
RA   Williams, Steven G.
RA   Wu, Yang-Xiu
RA   Xavier, Dylan
RA   MacKenzie, Karen L.
RA   Hains, Peter G.
RA   Tully, Brett
RA   Robinson, Phillip James
RA   Zhong, Qing
RA   Garnett, Mathew J.
RA   Reddel, Roger Robert
RT   "Pan-cancer proteomic map of 949 human cell lines.";
RL   Cancer Cell 40:835-849.e8(2022).
//
RX   PubMed=12529668; DOI=10.1038/sj.leu.2402740;
RA   Quentmeier, Hilmar
RA   Reinhardt, Julia
RA   Zaborski, Margarete
RA   Drexler, Hans Gunther
RT   "FLT3 mutations in acute myeloid leukemia cell lines.";
RL   Leukemia 17:120-124(2003).
//
RX   PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254;
RA   Nusinow, David Paul
RA   Szpyt, John
RA   Ghandi, Mahmoud
RA   Rose, Christopher M.
RA   McDonald, E. Robert 3rd
RA   Kalocsay, Marian
RA   Jane-Valbuena, Judit
RA   Gelfand, Ellen T.
RA   Schweppe, Devin Karl
RA   Jedrychowski, Mark P.
RA   Golji, Javad
RA   Porter, Dale A.
RA   Rejtar, Tomas
RA   Wang, Y. Karen
RA   Kryukov, Gregory V.
RA   Stegmeier, Frank
RA   Erickson, Brian K.
RA   Garraway, Levi Alexander
RA   Sellers, William Raj
RA   Gygi, Steven P.
RT   "Quantitative proteomics of the Cancer Cell Line Encyclopedia.";
RL   Cell 180:387-402.e16(2020).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076;
RA   Li, Jun
RA   Zhao, Wei
RA   Akbani, Rehan
RA   Liu, Wen-Bin
RA   Ju, Zhen-Lin
RA   Ling, Shi-Yun
RA   Vellano, Christopher P.
RA   Roebuck, Paul
RA   Yu, Qing-Hua
RA   Eterovic, Agda Karina
RA   Byers, Lauren Averett
RA   Davies, Michael A.
RA   Deng, Wan-Leng
RA   Gopal, Y.N. Vashisht
RA   Chen, Guo
RA   von Euw, Erika Maria
RA   Slamon, Dennis Joseph
RA   Conklin, Dylan
RA   Heymach, John Victor
RA   Gazdar, Adi F.
RA   Minna, John D.
RA   Myers, Jeffrey N.
RA   Lu, Yi-Ling
RA   Mills, Gordon B.
RA   Liang, Han
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=25984343; DOI=10.1038/sdata.2014.35; PMCID=PMC4432652;
RA   Cowley, Glenn S.
RA   Weir, Barbara A.
RA   Vazquez, Francisca
RA   Tamayo, Pablo
RA   Scott, Justine A.
RA   Rusin, Scott
RA   East-Seletsky, Alexandra
RA   Ali, Levi D.
RA   Gerath, William F.J.
RA   Pantel, Sarah E.
RA   Lizotte, Patrick Hall
RA   Jiang, Guo-Zhi
RA   Hsiao, Jessica
RA   Tsherniak, Aviad
RA   Dwinell, Elizabeth
RA   Aoyama, Simon
RA   Okamoto, Michael
RA   Harrington, William
RA   Gelfand, Ellen T.
RA   Green, Thomas M.
RA   Tomko, Mark J.
RA   Gopal, Shuba
RA   Wong, Terence C.
RA   Li, Hu-Bo
RA   Howell, Sara
RA   Stransky, Nicolas
RA   Liefeld, Ted
RA   Jang, Dongkeun
RA   Bistline, Jonathan
RA   Meyers, Barbara Hill
RA   Armstrong, Scott Allen
RA   Anderson, Kenneth Carl
RA   Stegmaier, Kimberly
RA   Reich, Michael
RA   Pellman, David
RA   Boehm, Jesse S.
RA   Mesirov, Jill P.
RA   Golub, Todd Robert
RA   Root, David E.
RA   Hahn, William Chun
RT   "Parallel genome-scale loss of function screens in 216 cancer cell
RT   lines for the identification of context-specific genetic
RT   dependencies.";
RL   Sci. Data 1:140035.1-140035.12(2014).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469;
RA   Iorio, Francesco
RA   Knijnenburg, Theo A.
RA   Vis, Daniel J.
RA   Bignell, Graham Robert
RA   Menden, Michael Patrick
RA   Schubert, Michael
RA   Aben, Nanne
RA   Goncalves, Emanuel
RA   Barthorpe, Syd
RA   Lightfoot, Howard
RA   Cokelaer, Thomas
RA   Greninger, Patricia
RA   van Dyk, Ewald
RA   Chang, Han
RA   de Silva, Heshani
RA   Heyn, Holger
RA   Deng, Xian-Ming
RA   Egan, Regina K.
RA   Liu, Qing-Song
RA   Mironenko, Tatiana
RA   Mitropoulos, Xeni
RA   Richardson, Laura
RA   Wang, Jin-Hua
RA   Zhang, Ting-Hu
RA   Moran, Sebastian
RA   Sayols, Sergi
RA   Soleimani, Maryam
RA   Tamborero, David
RA   Lopez-Bigas, Nuria
RA   Ross-Macdonald, Petra
RA   Esteller, Manel
RA   Gray, Nathanael S.
RA   Haber, Daniel Arie
RA   Stratton, Michael Rudolf
RA   Benes, Cyril Henri
RA   Wessels, Lodewyk F.A.
RA   Saez-Rodriguez, Julio
RA   McDermott, Ultan
RA   Garnett, Mathew J.
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=23955599; DOI=10.1038/ng.2731;
RA   Kon, Ayana
RA   Shih, Lee-Yung
RA   Minamino, Masashi
RA   Sanada, Masashi
RA   Shiraishi, Yuichi
RA   Nagata, Yasunobu
RA   Yoshida, Ken-ichi
RA   Okuno, Yusuke
RA   Bando, Masashige
RA   Nakato, Ryuichiro
RA   Ishikawa, Shumpei
RA   Sato-Otsubo, Aiko
RA   Nagae, Genta
RA   Nishimoto, Aiko
RA   Haferlach, Claudia
RA   Nowak, Daniel
RA   Sato, Yusuke
RA   Alpermann, Tamara
RA   Nagasaki, Masao
RA   Shimamura, Teppei
RA   Tanaka, Hiroko
RA   Chiba, Kenichi
RA   Yamamoto, Ryo
RA   Yamaguchi, Tomoyuki
RA   Otsu, Makoto
RA   Obara, Naoshi
RA   Sakata-Yanagimoto, Mamiko
RA   Nakamaki, Tsuyoshi
RA   Ishiyama, Ken
RA   Nolte, Florian
RA   Hofmann, Wolf-Karsten
RA   Miyawaki, Shuichi
RA   Chiba, Shigeru
RA   Mori, Hiraku
RA   Nakauchi, Hiromitsu
RA   Koeffler, Harold Phillip
RA   Aburatani, Hiroyuki
RA   Haferlach, Torsten
RA   Shirahige, Katsuhiko
RA   Miyano, Satoru
RA   Ogawa, Seishi
RT   "Recurrent mutations in multiple components of the cohesin complex in
RT   myeloid neoplasms.";
RL   Nat. Genet. 45:1232-1237(2013).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103;
RA   Ghandi, Mahmoud
RA   Huang, Franklin W.
RA   Jane-Valbuena, Judit
RA   Kryukov, Gregory V.
RA   Lo, Christopher C.
RA   McDonald, E. Robert 3rd
RA   Barretina, Jordi Ginesta
RA   Gelfand, Ellen T.
RA   Bielski, Craig M.
RA   Li, Hao-Xin
RA   Hu, Kevin
RA   Andreev-Drakhlin, Alexander Y.
RA   Kim, Jaegil
RA   Hess, Julian M.
RA   Haas, Brian J.
RA   Aguet, Francois
RA   Weir, Barbara A.
RA   Rothberg, Michael V.
RA   Paolella, Brenton R.
RA   Lawrence, Michael Scott
RA   Akbani, Rehan
RA   Lu, Yi-Ling
RA   Tiv, Hong L.
RA   Gokhale, Prafulla C.
RA   de Weck, Antoine
RA   Mansour, Ali Amin
RA   Oh, Coyin
RA   Shih, Juliann
RA   Hadi, Kevin
RA   Rosen, Yanay
RA   Bistline, Jonathan
RA   Venkatesan, Kavitha
RA   Reddy, Anupama
RA   Sonkin, Dmitriy
RA   Liu, Manway
RA   Lehar, Joseph
RA   Korn, Joshua M.
RA   Porter, Dale A.
RA   Jones, Michael D.
RA   Golji, Javad
RA   Caponigro, Giordano
RA   Taylor, Jordan E.
RA   Dunning, Caitlin M.
RA   Creech, Amanda L.
RA   Warren, Allison C.
RA   McFarland, James M.
RA   Zamanighomi, Mahdi
RA   Kauffmann, Audrey
RA   Stransky, Nicolas
RA   Imielinski, Marcin
RA   Maruvka, Yosef E.
RA   Cherniack, Andrew D.
RA   Tsherniak, Aviad
RA   Vazquez, Francisca
RA   Jaffe, Jacob D.
RA   Lane, Andrew Alan
RA   Weinstock, David M.
RA   Johannessen, Cory M.
RA   Morrissey, Michael P.
RA   Stegmeier, Frank
RA   Schlegel, Robert
RA   Hahn, William Chun
RA   Getz, Gad
RA   Mills, Gordon B.
RA   Boehm, Jesse S.
RA   Golub, Todd Robert
RA   Garraway, Levi Alexander
RA   Sellers, William Raj
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//
RX   PubMed=22354205; DOI=10.1038/leu.2012.52; PMCID=PMC3523391;
RA   Moore, Andrew S.
RA   Faisal, Amir
RA   Gonzalez de Castro, David
RA   Bavetsias, Vassilios
RA   Sun, Chong-Bo
RA   Atrash, Butrus
RA   Valenti, Melanie
RA   De Haven Brandon, Alexis Katherine
RA   Avery, Sian
RA   Mair, Debbie
RA   Mirabella, Fabio
RA   Swansbury, John
RA   Pearson, Andrew D.J.
RA   Workman, Paul
RA   Blagg, Julian
RA   Raynaud, Florence I.
RA   Eccles, Suzanne A.
RA   Linardopoulos, Spiros
RT   "Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia
RT   resulting in secondary D835Y mutation: a model for emerging clinical
RT   resistance patterns.";
RL   Leukemia 26:1462-1470(2012).
//
RX   PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646;
RA   Quentmeier, Hilmar
RA   Pommerenke, Claudia
RA   Dirks, Wilhelm Gerhard
RA   Eberth, Sonja
RA   Koeppel, Max
RA   MacLeod, Roderick A.F.
RA   Nagel, Stefan
RA   Steube, Klaus G.
RA   Uphoff, Cord C.
RA   Drexler, Hans Gunther
RT   "The LL-100 panel: 100 cell lines for blood cancer studies.";
RL   Sci. Rep. 9:8218.1-8218.14(2019).
//
RX   PubMed=28109323; DOI=10.1186/s13045-017-0396-0; PMCID=PMC5251306;
RA   Masetti, Riccardo
RA   Bertuccio, Salvatore Nicola
RA   Astolfi, Annalisa
RA   Chiarini, Francesca
RA   Lonetti, Annalisa
RA   Indio, Valentina
RA   De Luca, Matilde
RA   Bandini, Jessica
RA   Serravalle, Salvatore
RA   Franzoni, Monica
RA   Pigazzi, Martina
RA   Martelli, Alberto Maria
RA   Basso, Giuseppe
RA   Locatelli, Franco
RA   Pession, Andrea
RT   "Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion
RT   gene.";
RL   J. Hematol. Oncol. 10:26.1-26.5(2017).
//
RX   PubMed=27750403; DOI=10.1002/gcc.22430;
RA   Palau, Anna
RA   Mallo, Mar
RA   Palomo, Laura
RA   Rodriguez-Hernandez, Ines
RA   Diesch, Jeannine
RA   Campos, Diana
RA   Granada, Isabel
RA   Junca, Jordi
RA   Drexler, Hans Gunther
RA   Sole, Francesc
RA   Buschbeck, Marcus
RT   "Immunophenotypic, cytogenetic, and mutational characterization of
RT   cell lines derived from myelodysplastic syndrome patients after
RT   progression to acute myeloid leukemia.";
RL   Genes Chromosomes Cancer 56:243-252(2017).
//
RX   PubMed=10233379; DOI=10.1111/j.1365-2141.1999.01284.x;
RA   Xu, Feng
RA   Taki, Tomohiko
RA   Yang, Hong-Wei
RA   Hanada, Ryoji
RA   Hongo, Teruaki
RA   Ohnishi, Hiroaki
RA   Kobayashi, Miyuki
RA   Bessho, Fumio
RA   Yanagisawa, Masayoshi
RA   Hayashi, Yasuhide
RT   "Tandem duplication of the FLT3 gene is found in acute lymphoblastic
RT   leukaemia as well as acute myeloid leukaemia but not in
RT   myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in
RT   children.";
RL   Br. J. Haematol. 105:155-162(1999).
//
RX   PubMed=29491412; DOI=10.1038/s41388-018-0150-2; PMCID=PMC5955861;
RA   Gerlach, Daniel
RA   Tontsch-Grunt, Ulrike
RA   Baum, Anke
RA   Popow, Johannes
RA   Scharn, Dirk
RA   Hofmann, Marco H.
RA   Engelhardt, Harald
RA   Kaya, Onur
RA   Beck, Janina
RA   Schweifer, Norbert
RA   Gerstberger, Thomas
RA   Zuber, Johannes
RA   Savarese, Fabio
RA   Kraut, Norbert
RT   "The novel BET bromodomain inhibitor BI 894999 represses
RT   super-enhancer-associated transcription and synergizes with CDK9
RT   inhibition in AML.";
RL   Oncogene 37:2687-2701(2018).
//
RX   PubMed=33669837; DOI=10.3390/ijms22042076; PMCID=PMC7923013;
RA   Janotka, Lubos
RA   Messingerova, Lucia
RA   Simonicova, Kristina
RA   Kavcova, Helena
RA   Elefantova, Katarina
RA   Sulova, Zdena
RA   Breier, Albert
RT   "Changes in apoptotic pathways in MOLM-13 cell lines after induction
RT   of resistance to hypomethylating agents.";
RL   Int. J. Mol. Sci. 22:2076.1-2076.24(2021).
//
RX   PubMed=10739008; DOI=10.1016/S0145-2126(99)00182-4;
RA   Inoue, Kaoru
RA   Kohno, Takashi
RA   Takakura, Satoshi
RA   Hayashi, Yasuhide
RA   Mizoguchi, Hideaki
RA   Yokota, Jun
RT   "Frequent microsatellite instability and BAX mutations in T cell acute
RT   lymphoblastic leukemia cell lines.";
RL   Leuk. Res. 24:255-262(2000).
//
RX   PubMed=14671638; DOI=10.1038/sj.leu.2403236;
RA   Drexler, Hans Gunther
RA   Quentmeier, Hilmar
RA   MacLeod, Roderick A.F.
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   MLL gene alterations.";
RL   Leukemia 18:227-232(2004).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675;
RA   Dutil, Julie
RA   Chen, Zhi-Hua
RA   Monteiro, Alvaro N.A.
RA   Teer, Jamie K.
RA   Eschrich, Steven A.
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=28052028; DOI=10.18632/oncotarget.14342; PMCID=PMC5355301;
RA   Hur, Eun-Hye
RA   Jung, Seung-Hyun
RA   Goo, Bon-Kwan
RA   Moon, Juhyun
RA   Choi, Yunsuk
RA   Choi, Dae Ro
RA   Chung, Yeun-Jun
RA   Lee, Je-Hwan
RT   "Establishment and characterization of hypomethylating agent-resistant
RT   cell lines, MOLM/AZA-1 and MOLM/DEC-5.";
RL   Oncotarget 8:11748-11762(2017).
//
RX   PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027;
RA   Barretina, Jordi Ginesta
RA   Caponigro, Giordano
RA   Stransky, Nicolas
RA   Venkatesan, Kavitha
RA   Margolin, Adam A.
RA   Kim, Sungjoon
RA   Wilson, Christopher J.
RA   Lehar, Joseph
RA   Kryukov, Gregory V.
RA   Sonkin, Dmitriy
RA   Reddy, Anupama
RA   Liu, Manway
RA   Murray, Lauren
RA   Berger, Michael F.
RA   Monahan, John E.
RA   Morais, Paula
RA   Meltzer, Jodi
RA   Korejwa, Adam
RA   Jane-Valbuena, Judit
RA   Mapa, Felipa A.
RA   Thibault, Joseph
RA   Bric-Furlong, Eva
RA   Raman, Pichai
RA   Shipway, Aaron
RA   Engels, Ingo H.
RA   Cheng, Jill
RA   Yu, Guo-Ying K.
RA   Yu, Jian-Jun
RA   Aspesi, Peter Jr.
RA   de Silva, Melanie
RA   Jagtap, Kalpana
RA   Jones, Michael D.
RA   Wang, Li
RA   Hatton, Charles
RA   Palescandolo, Emanuele
RA   Gupta, Supriya
RA   Mahan, Scott
RA   Sougnez, Carrie
RA   Onofrio, Robert C.
RA   Liefeld, Ted
RA   MacConaill, Laura Eleanor
RA   Winckler, Wendy
RA   Reich, Michael
RA   Li, Nan-Xin
RA   Mesirov, Jill P.
RA   Gabriel, Stacey B.
RA   Getz, Gad
RA   Ardlie, Kristin
RA   Chan, Vivien
RA   Myer, Vic E.
RA   Weber, Barbara L.
RA   Porter, Jeff
RA   Warmuth, Markus
RA   Finan, Peter
RA   Harris, Jennifer L.
RA   Meyerson, Matthew Langer
RA   Golub, Todd Robert
RA   Morrissey, Michael P.
RA   Sellers, William Raj
RA   Schlegel, Robert
RA   Garraway, Levi Alexander
RT   "The Cancer Cell Line Encyclopedia enables predictive modelling of
RT   anticancer drug sensitivity.";
RL   Nature 483:603-607(2012).
//
RX   PubMed=30629668; DOI=10.1371/journal.pone.0210404; PMCID=PMC6328144;
RA   Uphoff, Cord C.
RA   Pommerenke, Claudia
RA   Denkmann, Sabine A.
RA   Drexler, Hans Gunther
RT   "Screening human cell lines for viral infections applying RNA-Seq data
RT   analysis.";
RL   PLoS ONE 14:e0210404.1-e0210404.22(2019).
//
RX   PubMed=10637496; DOI=10.1038/sj.leu.2401604;
RA   Drexler, Hans Gunther
RA   Fombonne, Severine
RA   Matsuo, Yoshinobu
RA   Hu, Zhen-Bo
RA   Hamaguchi, Hiroyuki
RA   Uphoff, Cord C.
RT   "p53 alterations in human leukemia-lymphoma cell lines: in
RT   vitro artifact or prerequisite for cell immortalization?";
RL   Leukemia 14:198-206(2000).
//
RX   PubMed=9305600; DOI=10.1038/sj.leu.2400768;
RA   Matsuo, Yoshinobu
RA   MacLeod, Roderick A.F.
RA   Uphoff, Cord C.
RA   Drexler, Hans Gunther
RA   Nishizaki, Chiharu
RA   Katayama, Yoshio
RA   Kimura, Genki
RA   Fujii, Nobuharu
RA   Omoto, Eijiro
RA   Harada, Mine
RA   Orita, Kunzo
RT   "Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14)
RT   with interclonal phenotypic heterogeneity showing MLL-AF9 fusion
RT   resulting from an occult chromosome insertion,
RT   ins(11;9)(q23;p22p23).";
RL   Leukemia 11:1469-1477(1997).
//
RX   PubMed=15381384; DOI=10.1016/j.cancergencyto.2004.01.029;
RA   Montemurro, Luca
RA   Tonelli, Roberto
RA   Fazzina, Raffaella
RA   Martino, Vincenzo
RA   Marino, Flora
RA   Pession, Andrea
RT   "Identification of two MLL-MLLT3 (alias MLL-AF9) chimeric transcripts
RT   in the MOLM-13 cell line.";
RL   Cancer Genet. Cytogenet. 154:96-97(2004).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu, Ma-Mie
RA   Selvaraj, Suresh K.
RA   Liang-Chu, May M.Y.
RA   Aghajani, Sahar
RA   Busse, Matthew
RA   Yuan, Jean
RA   Lee, Genee
RA   Peale, Franklin V.
RA   Klijn, Christiaan
RA   Bourgon, Richard
RA   Kaminker, Joshua S.
RA   Neve, Richard M.
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=30285677; DOI=10.1186/s12885-018-4840-5; PMCID=PMC6167786;
RA   Tan, Kar-Tong
RA   Ding, Ling-Wen
RA   Sun, Qiao-Yang
RA   Lao, Zhen-Tang
RA   Chien, Wenwen
RA   Ren, Xi
RA   Xiao, Jin-Fen
RA   Loh, Xin-Yi
RA   Xu, Liang
RA   Lill, Michael
RA   Mayakonda, Anand
RA   Lin, De-Chen
RA   Yang, Henry He
RA   Koeffler, Harold Phillip
RT   "Profiling the B/T cell receptor repertoire of lymphocyte derived cell
RT   lines.";
RL   BMC Cancer 18:940.1-940.13(2018).
//
RX   PubMed=16408098; DOI=10.1038/sj.leu.2404081;
RA   Quentmeier, Hilmar
RA   MacLeod, Roderick A.F.
RA   Zaborski, Margarete
RA   Drexler, Hans Gunther
RT   "JAK2 V617F tyrosine kinase mutation in cell lines derived from
RT   myeloproliferative disorders.";
RL   Leukemia 20:471-476(2006).
//
RX   PubMed=36982453; DOI=10.3390/ijms24065377; PMCID=PMC10049680;
RA   Skopek, Rafal
RA   Palusinska, Malgorzata
RA   Kaczor-Keller, Katarzyna
RA   Pingwara, Rafal
RA   Papierniak-Wygladala, Anna
RA   Schenk, Tino
RA   Lewicki, Slawomir
RA   Zelent, Artur
RA   Szymanski, Lukasz
RT   "Choosing the right cell line for acute myeloid leukemia (AML)
RT   research.";
RL   Int. J. Mol. Sci. 24:5377.1-5377.34(2023).
//
RX   PubMed=11226526; DOI=10.1016/S0145-2126(00)00121-1;
RA   Inoue, Kaoru
RA   Kohno, Takashi
RA   Takakura, Satoshi
RA   Hayashi, Yasuhide
RA   Mizoguchi, Hideaki
RA   Yokota, Jun
RT   "Corrigendum to 'Frequent microsatellite instability and BAX mutations
RT   in T cell acute lymphoblastic leukemia cell lines' Leukemia Research 24
RT   (2000), 255-262.";
RL   Leuk. Res. 25:275-278(2001).
//